| Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda EJ Mills, C Bakanda, J Birungi, K Chan, N Ford, CL Cooper, JB Nachega, ... Annals of internal medicine 155 (4), 209-216, 2011 | 534 | 2011 |
| Improving effective surgical delivery in humanitarian disasters: lessons from Haiti K Chu, C Stokes, M Trelles, N Ford PLoS medicine 8 (4), e1001025, 2011 | 88 | 2011 |
| Conflict in the Indian Kashmir Valley I: exposure to violence K de Jong, N Ford, S van de Kam, K Lokuge, S Fromm, R van Galen, ... Conflict and Health 2, 1-7, 2008 | 80 | 2008 |
| Comparative safety and neuropsychiatric adverse events associated with efavirenz use in first-line antiretroviral therapy: a systematic review and meta-analysis of randomized … N Ford, Z Shubber, A Pozniak, M Vitoria, M Doherty, C Kirby, A Calmy JAIDS Journal of Acquired Immune Deficiency Syndromes 69 (4), 422-429, 2015 | 79 | 2015 |
| An integrated approach of community health worker support for HIV/AIDS and TB care in Angonia district, Mozambique S Simon, K Chu, M Frieden, B Candrinho, N Ford, H Schneider, M Biot BMC International Health and Human Rights 9, 1-7, 2009 | 61 | 2009 |
| HIV/AIDS prevention and treatment E Goemaere, N Ford, SR Benatar The Lancet 360 (9326), 86-87, 2002 | 59 | 2002 |
| World Health Organization guidelines on postexposure prophylaxis for HIV: recommendations for a public health approach N Ford, KH Mayer, ... Clinical Infectious Diseases 60 (suppl_3), S161-S164, 2015 | 56 | 2015 |
| Definitions of implementation science in HIV/AIDS TA Odeny, N Padian, MC Doherty, S Baral, C Beyrer, N Ford, EH Geng The lancet HIV 2 (5), e178-e180, 2015 | 53 | 2015 |
| The strategic use of antiretrovirals to prevent HIV infection: a converging agenda R Baggaley, M Doherty, A Ball, N Ford, G Hirnschall Clinical Infectious Diseases 60 (suppl_3), S159-S160, 2015 | 41 | 2015 |
| Editorial Commentary: Immunodeficiency at Start of Antiretroviral Therapy: The Persistent Problem of Late Presentation to Care N Ford, EJ Mills, M Egger Clinical infectious diseases 60 (7), 1128-1130, 2015 | 35 | 2015 |
| Ten priorities for expanding access to HCV treatment for people who inject drugs in low-and middle-income countries N Ford, S Wiktor, K Kaplan, I Andrieux-Meyer, A Hill, P Radhakrishnan, ... International Journal of Drug Policy 26 (11), 1088-1093, 2015 | 32 | 2015 |
| Strength of recommendations in WHO guidelines using GRADE was associated with uptake in national policy SMU Nasser, G Cooke, K Kranzer, SL Norris, P Olliaro, N Ford Journal of clinical epidemiology 68 (6), 703-707, 2015 | 31 | 2015 |
| Formulating the future research agenda for postexposure prophylaxis for HIV: methodological challenges and potential approaches N Siegfried, RL Beanland, N Ford, KH Mayer Clinical Infectious Diseases 60 (suppl_3), S205-S211, 2015 | 29 | 2015 |
| Preparing humanitarians to address ethical problems CR McGowan, L Baxter, M DuBois, J Sheather, R Khondaker, ... Conflict and Health 14, 1-7, 2020 | 12 | 2020 |
| Time to reduce CD4+ monitoring for the management of antiretroviral therapy in HIV-infected individuals WS Stevens, N Ford SAMJ: South African Medical Journal 104 (8), 558-559, 2014 | 12 | 2014 |
| The 2012 World Health Report ‘no health without research’: the endpoint needs to go beyond publication outputs R Zachariah, T Reid, N Ford, R Van den Bergh, A Dahmane, M Khogali, ... Tropical Medicine & International Health 17 (11), 1409-1411, 2012 | 11 | 2012 |
| The drug and vaccine landscape for neglected diseases (2000–11): A systematic assessment. Lancet Glob Health. 2013; 1: e371–9 B Pedrique, N Strub-Wourgaft, C Claudette Some, P Olliaro, P Trouiller, ... Single-dose tribendimidine+ oxantel pamoate 1, 0 | 11 | |
| Crossing borders: one world, global health CM Brown, MS Cetron Clinical Infectious Diseases 59 (1), v-vi, 2014 | 9 | 2014 |
| Maximising the benefits of home-based HIV testing R Ferrand, N Ford, K Kranzer The Lancet HIV 2 (1), e4-e5, 2015 | 8 | 2015 |
| Lifelong ART for 20 million people in sub-Saharan Africa: communities will be key for success T Decroo, N Ford, M Laga The Lancet Global Health 2 (5), e262-e263, 2014 | 8 | 2014 |
